retatrutide clinical trial dose retatrutide for weight loss: Study shows 30% body weight loss retatrutide clinical trial dosing frequency

The semaglutide versus tirzepatide comparison shows that the dual GIP/GLP-1 mechanism of tirzepatide consistently outperforms the GLP-1-only approach of semaglutide

Reference: Michiels C et al

Klausen M, Justesen S, Pedersen J et al.Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trialThe Lancet, 407, 1687-1698 Herman, Rae J

You should see a doctor if you experience any new or worsening vision changes, such as: blurred vision dark spots flashes of light sudden vision loss For people without diabetes or without existing eye disease, eye-related side effects are considered very unlikely

DSIP promotes delta wave activity during deep sleep stages, enhancing the most restorative phase of sleep where physical recovery, immune function, and memory consolidation occur optimally

Of those receiving GLP-1s, nearly all (97.5%) were receiving semaglutide